Study Evaluating TRU-015 in B-Cell Non-Hodgkin's Lymphoma

Clinical trial NCT00521638 · TERMINATED

Trial details

NCT number: NCT00521638
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, B-Cell

Start date: 2007-09-01
Primary completion: 2008-04-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.